Claversal
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
A 41-year-old man suffered from chronic diarrhoea of 3 years’ duration, accompanied by weight loss of 20 kg. He was referred to…
A 22-year-old woman with Crohn's disease was treated with 5-aminosalicylic acid (Claversal), four times 500 mg daily, because of…
ResumenObjetivo: Determinar si dos especialidades farmacéuticas orales de mesalazina (MES) (Claversal®, CLA y Pentasa®, PEN…
SIRS, We are very grateful to Treiber and colleagues for directing us towards their group's work in the ®eld of short-duration H…
Investigators: This multicentre study was conducted by 29 principal investigators in 11 countries.
Salazosulfapyridine was generated by Nanna Svartz in 1941. Mesalazine (5-ASA) was demonstrated in 1977 to be the therapeutically…
Crohn's recurrence is the appearance of objective signs--defined radiologically, endoscopically or pathologically--of Crohn's…
A randomized, double‐blind, placebo‐controlled multicentre study was undertaken to evaluate the safety and efficacy of coated…
Sulfasalazine has been the mainstay of therapy for ulcerative colitis and Crohn's disease of the colon. More recently, it has…